Approval · Notice of Compliance 13921 · 2012
SURVANTA: Notice of Compliance 13921
Issued November 30, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13921
- Date
- November 30, 2012
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Lung surfactant (bovine)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SURVANTA | 02016109 | Marketed |
Medicinal ingredients
- BERACTANT 25 MG per ML